Search research articles
Contact Us
Filters
Showing results (131-140 of 149) with videos related to
Page
of 15
Sort By:
Cancers
|
March 29, 2023
Subcellular Epithelial HMGB1 Expression Is Associated with Colorectal Neoplastic Progression, Male Sex, Mismatch Repair Protein Expression, Lymph Node Positivity, and an 'Immune Cold' Phenotype Associated with Poor Survival
Ross J Porter, Graeme I Murray, Sandra Hapca, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 12, 2012
Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up
P Colombat, N Brousse, G Salles, et al.
The British Journal of Dermatology
|
June 18, 2019
Efficacy and safety of brentuximab vedotin plus bendamustine in advanced-stage primary cutaneous T-cell lymphomas
M Dumont, C Ram-Wolff, M Roelens, et al.
The British Journal of Dermatology
|
January 21, 2014
Long-term efficacy and safety of alemtuzumab in advanced primary cutaneous T-cell lymphomas
A de Masson, P Guitera, P Brice, et al.
Leukemia
|
April 24, 1999
A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes. Groupe Français des Myélodysplasies. Group Ouest-Est d'étude des Leucémies aiguës myéloïdes
E Wattel, E Solary, X Leleu, et al.
The British Journal of Dermatology
|
July 7, 2019
Challenges in the diagnosis of primary cutaneous CD30<sup>+</sup> anaplastic large-cell lymphoma
G Dobos, M Battistella, F Jouenne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte
P Solal-Céligny, P Brice, N Brousse, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2014
ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥ 4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial
N Mounier, P Brice, S Bologna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 1999
Comparison of high-dose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure: a case-control study. Société Francaise de Greffe de Moelle
M André, M Henry-Amar, J L Pico, et al.
Autoimmunity Reviews
|
November 15, 2011
Hematological malignancy associated with polymyositis and dermatomyositis
I Marie, L Guillevin, J-F Menard, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 149) with videos related to
Sort By:
Page
of 15
Cancers
|
March 29, 2023
Subcellular Epithelial HMGB1 Expression Is Associated with Colorectal Neoplastic Progression, Male Sex, Mismatch Repair Protein Expression, Lymph Node Positivity, and an 'Immune Cold' Phenotype Associated with Poor Survival
Ross J Porter, Graeme I Murray, Sandra Hapca, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 12, 2012
Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up
P Colombat, N Brousse, G Salles, et al.
The British Journal of Dermatology
|
June 18, 2019
Efficacy and safety of brentuximab vedotin plus bendamustine in advanced-stage primary cutaneous T-cell lymphomas
M Dumont, C Ram-Wolff, M Roelens, et al.
The British Journal of Dermatology
|
January 21, 2014
Long-term efficacy and safety of alemtuzumab in advanced primary cutaneous T-cell lymphomas
A de Masson, P Guitera, P Brice, et al.
Leukemia
|
April 24, 1999
A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes. Groupe Français des Myélodysplasies. Group Ouest-Est d'étude des Leucémies aiguës myéloïdes
E Wattel, E Solary, X Leleu, et al.
The British Journal of Dermatology
|
July 7, 2019
Challenges in the diagnosis of primary cutaneous CD30<sup>+</sup> anaplastic large-cell lymphoma
G Dobos, M Battistella, F Jouenne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte
P Solal-Céligny, P Brice, N Brousse, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 16, 2014
ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥ 4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial
N Mounier, P Brice, S Bologna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 1999
Comparison of high-dose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure: a case-control study. Société Francaise de Greffe de Moelle
M André, M Henry-Amar, J L Pico, et al.
Autoimmunity Reviews
|
November 15, 2011
Hematological malignancy associated with polymyositis and dermatomyositis
I Marie, L Guillevin, J-F Menard, et al.
Page
of 15